Contrasting InnovAge (INNV) and Its Peers

InnovAge (NASDAQ:INNV) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it weigh in compared to its competitors? We will compare InnovAge to related businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for InnovAge and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InnovAge	1	2	1	0	2.00
InnovAge Competitors	1863	7734	13360	822	2.55

InnovAge currently has a consensus price target of $10.50, suggesting a potential upside of 12.06%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.01%. Given InnovAge’s competitors stronger consensus rating and higher possible upside, analysts plainly believe InnovAge has less favorable growth aspects than its competitors.

Valuation & Earnings

This table compares InnovAge and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
InnovAge	$989.71 million	-$2.54 million	156.17
InnovAge Competitors	$21.13 billion	$301.67 million	7.14

InnovAge’s competitors have higher revenue and earnings than InnovAge. InnovAge is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Insider and Institutional Ownership

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 1.1% of InnovAge shares are owned by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares InnovAge and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InnovAge	0.88%	3.63%	1.64%
InnovAge Competitors	-8.06%	-138.13%	-1.54%

Risk & Volatility

InnovAge has a beta of 0.16, meaning that its share price is 84% less volatile than the S&P 500. Comparatively, InnovAge’s competitors have a beta of 0.98, meaning that their average share price is 2% less volatile than the S&P 500.

Summary

InnovAge competitors beat InnovAge on 9 of the 13 factors compared.

About InnovAge

InnovAge, Inc. provides integrated healthcare and social services to older adults through the Program of All-Inclusive Care for the Elderly (PACE). The program serves people who qualify for nursing-home-level care but can continue living in their communities with coordinated support. InnovAge’s services include primary and specialty care coordination, nursing, rehabilitation, social services, prescription medications, transportation, in-home assistance and adult day health services. Care is coordinated by interdisciplinary teams and delivered through a combination of community-based centers and support at home.